Pre-transplant antibodies to Kα1 tubulin and collagen-V in lung transplantation: clinical correlations.

[1]  G. Patterson,et al.  Antibodies to K‐α 1 Tubulin and Collagen V Are Associated With Chronic Rejection After Lung Transplantation , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[2]  T. Mohanakumar,et al.  An important role for autoimmunity in the immunopathogenesis of chronic allograft rejection , 2012, International journal of immunogenetics.

[3]  G. Patterson,et al.  Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[4]  F. Tubach,et al.  Identification of periplakin as a new target for autoreactivity in idiopathic pulmonary fibrosis. , 2011, American journal of respiratory and critical care medicine.

[5]  C. Feghali-Bostwick,et al.  Autoimmunity in idiopathic pulmonary fibrosis: are circulating autoantibodies pathogenic or epiphenomena? , 2011, American journal of respiratory and critical care medicine.

[6]  A. Bharat,et al.  Antibodies to self-antigens predispose to primary lung allograft dysfunction and chronic rejection. , 2010, The Annals of thoracic surgery.

[7]  G. Patterson,et al.  Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[8]  T. Mohanakumar,et al.  Lipid raft facilitated ligation of K-alpha1-tubulin by specific antibodies on epithelial cells: Role in pathogenesis of chronic rejection following human lung transplantation. , 2010, Biochemical and biophysical research communications.

[9]  T. Mohanakumar,et al.  Virtual crossmatch by identification of donor-specific anti-human leukocyte antigen antibodies by solid-phase immunoassay: a 30-month analysis in living donor kidney transplantation. , 2010, Human immunology.

[10]  V. Aidinis,et al.  Global impairment of CD4+CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis. , 2009, American journal of respiratory and critical care medicine.

[11]  I. Durieu,et al.  Prevalence and clinical significance of auto-antibodies in adults with cystic fibrosis , 2009, European Respiratory Journal.

[12]  W. Chapman,et al.  Antibodies to MHC Class I Induce Autoimmunity: Role in the Pathogenesis of Chronic Rejection1 , 2009, The Journal of Immunology.

[13]  Gerald N. Smith,et al.  Anti-Type V Collagen Humoral Immunity in Lung Transplant Primary Graft Dysfunction1 , 2008, The Journal of Immunology.

[14]  G. Snell,et al.  C3d and C4d deposition early after lung transplantation. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[15]  G. Patterson,et al.  De Novo Production of K-α1 Tubulin-Specific Antibodies: Role in Chronic Lung Allograft Rejection1 , 2008, The Journal of Immunology.

[16]  O. Cummings,et al.  IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. , 2007, The Journal of clinical investigation.

[17]  E. Trulock,et al.  Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report-2007. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[18]  A. Bharat,et al.  Induction of IL-10 Suppressors in Lung Transplant Patients by CD4+25+ Regulatory T Cells through CTLA-4 Signaling1 , 2006, The Journal of Immunology.

[19]  A. Bharat,et al.  CD4+25+ Regulatory T Cells Limit Th1‐Autoimmunity by Inducing IL‐10 Producing T Cells Following Human Lung Transplantation , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[20]  E. Trulock,et al.  Bronchiolitis obliterans syndrome: pathogenesis and management. , 2004, Seminars in thoracic and cardiovascular surgery.

[21]  K. Savik,et al.  Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome. , 2002, Transplantation.

[22]  G. Patterson,et al.  Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation. , 1999, Transplantation.

[23]  G. Patterson,et al.  Temporal relationship between the development of anti-HLA antibodies and the development of bronchiolitis obliterans syndrome after lung transplantation. , 1999, Transplantation proceedings.

[24]  G. Patterson,et al.  Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome. , 1998, The Journal of thoracic and cardiovascular surgery.

[25]  G. Patterson,et al.  HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome. , 1998, Transplantation.

[26]  T. Mohanakumar,et al.  HIF-1α signaling by airway epithelial cell K-α1-tubulin: role in fibrosis and chronic rejection of human lung allografts. , 2012, Cellular immunology.

[27]  T. Mohanakumar,et al.  Molecular mechanisms of chronic rejection following transplantation , 2005, Immunologic research.

[28]  G. Patterson,et al.  Concomitant allorecognition of mismatched donor HLA class I- and class II-derived peptides in pediatric lung transplant recipients with bronchiolitis obliterans syndrome. , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.